Sepsis is one of the common causes of acute renal failure (ARF). The objective of this study was to identify new biomarkers and therapeutic targets. We present a new rat model of sepsis-induced ARF based on cecal ligation and puncture (CLP). We used this model to find urinary proteins which may be potential biomarkers and/or drug targets. Aged rats were treated with fluids and antibiotics after CLP. Urinary proteins from septic rats without ARF and urinary proteins from septic rats with ARF were compared by difference in-gel electrophoresis (DIGE). CLP surgery elevated interleukin (IL)-6 and IL-10 serum cytokines and blood nitrite compared with sham-operated rats. However, there was a range of serum creatinine values at 24 h (0.4-2.3 mg/dl) and only 24% developed ARF. Histology confirmed renal injury in these rats. Forty-nine percent of rats did not develop ARF. Rats without ARF also had less liver injury. The mortality rate at 24 h was 27% but was increased by housing the postsurgery rats in metabolic cages. Creatinine clearance and urine output 2-8 h after CLP was significantly reduced in rats which died within 24 h. Using DIGE we identified changes in a number of urinary proteins including albumin, brush-border enzymes (e.g., meprin-1-alpha) and serine protease inhibitors. The meprin-1-alpha inhibitor actinonin prevented ARF in aged mice. In summary, we describe a new rat model of sepsis-induced ARF which has a heterogeneous response similar to humans. This model allowed us to use DIGE to find changes in urinary proteins and this approach identified a potential biomarker and drug target -meprin-1-alpha. Sepsis is one of the most common causes of acute renal failure (ARF) and, despite extensive investigation, continues to have a high mortality.
Sepsis is one of the most common causes of acute renal failure (ARF) and, despite extensive investigation, continues to have a high mortality. [1] [2] [3] There have been few successful clinical trials although recent studies have shown that novel therapies targeting coagulation (activated protein C) and glucose control (intensive insulin therapy) can alter the prognosis of humans with sepsis. 4, 5 New animal models that better mimic human sepsis combined with advances in proteomic techniques may lead to the discovery of more biomarkers and novel therapeutic targets.
The cecal ligation and puncture (CLP) model is one of the commonly used animal models of polymicrobial sepsis. Our laboratory recently developed a clinically relevant model of sepsis in aged mice that are treated, like patients, with fluid resuscitation and broad-spectrum antibiotics. 6, 7 In this model, the mice consistently develop ARF in the context of multi-organ injury. This allowed us to demonstrate that the novel anti-inflammatory drug, ethyl pyruvate, was effective at reducing renal injury even when administered after induction of sepsis. 6, 7 However, any mouse model has limitations especially with regard to collection of biofluids such as urine. Therefore, in this paper we develop and characterize a treated CLP model in rats and obtain sufficient urine to discover urinary proteins which may represent biomarkers or new targets for drug development.
To investigate changes in the abundance of urinary proteins we used two-dimensional (2D) difference in-gel electrophoresis (DIGE). This technique is based on labeling of protein samples with either Cy3 or Cy5 fluorescent dyes then running both samples on the same 2D gel to eliminate gel to gel variability. The Cy3-and Cy5-labeled proteins can then be imaged and changes in protein abundance quantified. The proteins which have changed can then be identified by mass spectrometry. This technique has been successfully applied in a range of scenarios such as the identification of kidney inner medullary collecting duct proteins, 8 markers of liver toxicity, 9 and cancer-specific proteins. 10 In this paper, we use DIGE to compare urinary proteins from septic rats with ARF (responders) to septic rats without ARF (non-responders). An objective of this comparison was to find new drug targets for sepsis-induced ARF, therefore we tested the effect of an inhibitor of one of the urinary proteins identified by DIGE.
RESULTS
Characterization of the fluid-and antibiotic-treated sepsis model in aged rats (Group 1 -no urine collection) CLP did not produce renal injury in young rats (unpublished observation) so aged Sprague-Dawley rats (retired breeders) were used. To develop a clinically relevant model, we treated the animals with fluids and antibiotics at 6 and 18 h after surgery ( Figure 1 ). This time course was chosen because the animals become unwell at around 6 h and we wanted to mimic the time delay typically seen in humans between onset of sepsis and presentation to a physician. A heterogeneous response in renal function was seen in this model. There was a wide range of serum creatinine values at 24 h post-CLP (0.4-2.3 mg/dl) and 24% developed ARF defined as a twofold increase in creatinine (X0.8 mg/dl, the sepsis-ARF group) ( Figure 2 , white bars). Figure 2 also groups rats by the RIFLE criteria, a staging classification for human ARF (Acute Dialysis Quality Initiative, http://www.ADQI.net). Approximately 49% of the animals did not develop ARF (sepsis-no ARF group) (creatinine o0.8 mg/dl). The mortality rate at 24 h was 27%; these animals died without discernment of serum creatinine at 24 h. This was a pattern that was similar to humans, as about 30% of septic intensive care units patients develop ARF, and the mortality rate from sepsis ranges from 26 to 82%. [1] [2] [3] The heterogeneity of this model complicates the testing of therapeutic agents, in contrast to our CLP mouse model, which has a more consistent response. However, the rat model heterogeneity was useful for identifying pathophysiological differences between 'responders' (sepsis-ARF group) and 'non-responders' (sepsis-no ARF group).
Effect of CLP on organ injury
Previously, we have shown significant multi-organ injury in a similar CLP model with fluid and antibiotic treatment in mice where X80% of all animals developed ARF. 6 The new CLP model in rats also showed multiple organ injury with a difference observed between the septic-no ARF and septic-ARF groups ( Figure 3 ). The data presented in Figure 3 were collected from rats which were not housed in a metabolic cage (group 1). Liver injury was present as the enzymes alanine transaminase, aspartate transaminase (AST) and alkaline phosphatase were increased at 24 h after CLP. The increase in alanine transaminase and AST was significantly greater in rats with ARF.
Similar to the mouse model, lactate dehydrogenase (LDH) and amylase in the rat model also increased after CLP, amylase to a greater extent in the sepsis-ARF group (Figure 4) . Uric acid was slightly decreased 24 h after CLP, which supports the absence of volume depletion in this model (Figure 4 ).
Renal and hepatic injury
Kidney and liver sections were taken at 0, 8, and 24 h and stained with periodic acid-Schiff reagent. Renal histology at Time course of cytokine and nitrite response to sepsis
Induction of pro-and anti-inflammatory cytokines has been well documented in sepsis. 11 We investigated the time course of the cytokine response by measuring interleukin (IL)-6, IL-10 and Tumor necrosis factor (TNF)-a at 8 and 24 h after CLP or sham surgery. The pro-inflammatory cytokine IL-6 and anti-inflammatory cytokine IL-10 were significantly increased in all CLP animals compared to sham animals at 8 h (Figure 5a ) and 24 h (Figure 5a ) after surgery. There was also a significantly greater increase in the animals that developed ARF over the ones that did not. Serum TNF-a was undetectable (o12.5 pg/ml) in all groups at 8 and 24 h (data not shown).
Nitric oxide (NO) has been shown to be elevated in septic patients, however, the role of NO in the pathophysiology of sepsis is unclear. 12 We measured nitrite in the blood as an estimate of NO. Nitrite levels in the blood were altered after CLP both at 8 and 24 h post-surgery (Figure 5c ). Nitrite levels were significantly increased above normal by 8 h after CLP and an even greater increase was seen at 24 h.
Urinary changes after sepsis -Group 2
We investigated changes in urine output and creatinine clearance by collecting rat urine in a metabolic cage, which increased the death rate of the model from 27 to 62% (Figure 2, black bars) . The use of the metabolic cages prevented the animals from being housed at 291C after surgery as was carried out with the other animals. Also, with the use of the cages, the animals were given fluids at 8 h instead of 6 h. Other factors such as age, weight, surgical technique, number of days housed, etc. could not explain this effect. The use of the metabolic cage only induced a change in the rates of ARF and death and otherwise renal histology, cytokine, and liver enzyme responses were indistinguishable between these groups (data not shown).
Urine output decreased almost immediately after surgery in all septic animals as compared to pre-surgery urine output. When animals were grouped by 24-h outcome, there was a greater decrease in urine output in animals that did not survive to 24 h than in the survivors, however, this difference was not significant (Figure 6a ). These findings are consistent with previous observations that septic mice produce a significantly reduced volume of urine shown by a new magnetic resonance imaging technique. 7 Changes in creatinine clearance were seen early after the onset of sepsis ( Figure  6b ). As expected, the decrease in creatinine clearance was dependent upon the severity of renal injury at 8 h shown by the reciprocal relationship between rising 8 h serum creatinine and decreasing creatinine clearance (not shown). The early change in creatinine clearance was also related to the 24-h outcome as the animals that did not survive to 24 h had a mean 40% decrease in creatinine clearance where as sham animals and survivors had a mean 25% increase in creatinine clearance ( Figure 6b ).
Urinary proteomics
We used electrophoresis to compare the urinary proteome from three rats with sepsis but normal renal function (serum creatinine before surgery ¼ 0.570.03 mg/dl; at 8 h after CLP surgery ¼ 0.670.1 mg/dl (n ¼ 3) with the urinary proteome from three septic rats with ARF (serum creatinine before surgery ¼ 0.470.1 mg/dl; at 8 h after CLP surgery ¼ 1.370.3 mg/dl (n ¼ 3)). The urine was collected from 2 to 8 h after CLP surgery (sepsis-no ARF, urine volume 2.270.7 ml sepsis-ARF, urine volume 1.770.3 ml). In this time period, there was a large variation in the amount of protein excreted by each rat within the two groups (sepsis-no ARF group, 0.3, 1.4, 7.6 mg; sepsis-ARF, 1.5, 2.5, 6.3 mg). Initial studies showed that this variation was largely due to differences in production of prostatic proteins. Figure 7 shows a 2D gel image of the abundant protein ventral prostate-specific protein from two rats without ARF. The amount released into the urine was clearly very different. To manage this variability we pooled urine samples from three rats without ARF and compared this with pooled urine samples from three rats with ARF. In this time period, the three rats without ARF excreted a total of 9.4 mg of urinary protein. The three rats with ARF excreted a total of 10.3 mg of urinary protein. Therefore, the amount of protein excreted per group was similar.
After precipitation of the urinary protein, the amount of protein excreted in the urine in 1.48 min was labeled with Cy3 (no ARF) or Cy5 (ARF). This time period was chosen as the amount of protein excreted in both groups was near to 50 mg, the optimal amount for minimal labeling with Cy dyes. The samples were then separated by isoelectric focusing in the first dimension and molecular weight in the second dimension to produce a 2D gel image ( Figure 8 ). Red spots indicate an increased relative abundance in the sepsis-ARF rats. Green indicates a decreased relative abundance and yellow spots are unchanged in relative abundance. By pooling the samples, the amount of prostatic protein excreted did not change in relative abundance. Therefore, we could readily detect changes in proteins associated with renal injury.
2D gel electrophoresis was performed in triplicate and, using DeCyder software, spots were selected for identification by matrix-assisted laser desorption/ionization-time-offlight-time-of-flight if there was a change in relative abundance and the change was significant (Po0.05 by t-test). In total, 97 spots were selected of which 30 were correctly identified. Identification was considered correct if the MS peptide mass fingerprinting score was above 95% and the measured molecular weight and isoelectric point matched the expected values (Table 1) .
Three groups of proteins were found to change in relative abundance with ARF ( Figure 9 ). Circulating proteins such as albumin were increased, serine protease inhibitors (SPIs) were decreased and 'kidney specific' proteins were either increased (aminopeptidase) or decreased (meprin-1-alpha). Given the small number of differentially expressed protein spots and fewer subsequently identified proteins, there are limitations to this proteomic strategy, but it is suitable for protein discovery as long as the candidate biomarkers are subsequently validated. We validated the 2D gel results by performing a western blot for meprin-1-alpha on independently obtained samples. Meprin was strongly excreted in sepsis-no ARF rats ( Figure  10 -last three lanes) but not detected in urine from rats with sepsis and ARF ( Figure 10 -first three lanes).
Drug-target validation
Brush border enzymes changed in abundance and correlated with renal injury. Actinonin, an inhibitor of the brush-border enzymes (especially meprin-1-alpha) was given to the CLP mouse model described by our lab previously 6 at 0 and 6 h after surgery (400 mg). The mouse model was used as renal injury is more consistent than in rats and makes correct detection of a positive or negative drug effect more likely with a given number of animals. Mice treated with actinonin had a lower serum creatinine compared with vehicle-treated mice 24 h after CLP (Figure 11 ).
DISCUSSION
The new rat model of sepsis-induced ARF had a heterogeneous response that was similar to the human disease. This heterogeneity allowed responders to be compared to nonresponders using proteomics to detect potential urinary biomarkers and drug targets. Actinonin, a brush-border enzyme inhibitor, protected renal function in our mouse sepsis model, similar to data reported for ischemic renal injury. 13 This demonstrates the potential of proteomics in drug-target discovery.
Model of sepsis-induced ARF that is clinically relevant to the human disease
We developed a rat model of sepsis-induced ARF based on the polymicrobial CLP model but with two distinct features that may make this model clinically relevant. First, animals were treated with fluid resuscitation and broad-spectrum antibiotics, and second, aged rather than young rats were used. Previous studies based on the CLP model have not included fluid and antibiotic treatment, which is standard treatment for septic patients. Fluid and antibiotic treatment alters outcome after CLP and makes a rodent model more consistent with clinical practice. 14, 15 In our rat model, fluid and antibiotic treatment was not started until 6 h after CLP to mimic the delay typically seen in the presentation of human sepsis. The second distinct feature of this model was the use of aged rats. Sepsis-induced ARF is more commonly a disease of the elderly as those with sepsis-induced ARF are, on average, older than those with other forms of ARF. 16 The prognosis of sepsis-induced ARF in the elderly is poor with an increase in mortality with aging from 10% in children to 38.4% in those 485 years old. 17 Aged rats were also used because young rats either died or did not develop CLPinduced ARF in our lab when treated with fluids and antibiotics (unpublished observation). Saito et al., found similar results in aged vs young mice using the CLP model. 18 A unique feature of this model was the heterogeneous response to sepsis that is similar to humans. In the animals that survived, serum creatinine values ranged from 0.4 to 2.3 mg/dl and there was a 27% mortality rate at 24 h. Twentyfour percent of the rats developed ARF, which is a pattern similar to humans as 19-23% of moderate to severe septic patients develop ARF. 19 The mortality rate of 27% in our rat model was also similar to humans. Hotchkiss et al. found that the mortality rate in patients admitted to the intensive care units with sepsis was nearly 30%. 20 Therefore, our new rat model is clinically relevant to the human disease as it closely mimics the human response to sepsis. The reasons for the variability in our model are not understood. Since the model generates animals what have sepsis both without and with ARF, the confounding effects of sepsis that are independent of ARF can be isolated and studied. Also, the wide span in disease severity allows potential disease biomarkers or candidate mediators to be tested over a wide range of disease severity. However, testing therapeutic agents in such a variable model requires large numbers of animals, in part because animals that do not develop ARF cannot be easily distinguished from those that benefit from the agent.
In some animals, metabolic cages were used to collect the urine. The use of the cages altered the response of the model to increase the death rate from 27 to 62%. We hypothesize that the use of the metabolic cage and housing the animals at room temperature for the 24 h after surgery, rather than at 291C, caused additional stress on the animals which may account for the increased death rate. These animals were given fluids at 8 h instead of at 6 h, which may also be partially responsible for the increased death rate.
The urine changes observed in the new sepsis model demonstrated further similarities to the human disease. In the rat model, sepsis-no ARF and sepsis-ARF groups had oliguria and a decrease in creatinine clearance. These changes were detected early after the onset of sepsis. The oliguria in Table 1 . The spot labeled A is ventral prostate-specific protein which did not change in abundance.
the rat model was greater in the animals that did not survive compared to the survivors, however, this was not significant. This is similar to human septic ARF, as oliguria has been found to be a predictor of mortality and the chance of survival decreases once oliguria becomes resistant to volume replacement. 16, 17 Creatinine clearance decreased early corresponding to the severity of sepsis and renal injury. There was an early decrease in the animals that did not survive to 24 h as described in human sepsis.
This new sepsis model in rats resulted in multi-organ injury despite antibiotic treatment and fluid resuscitation. There were also differences in the severity of multi-organ injury observed between the animals that did and did not develop ARF. Enzyme markers of hepatic and pancreatic injury showed greater elevation in the animals with ARF. Renal injury was documented by serum creatinine and histology. Despite some early rises in serum creatinine at 8 h, renal injury was not detected by histology until 24 h. Hepatic injury, however, was detectable by histology 8 h after CLP and the severity of injury increased at 24 h. Liver injury was also more severe in the animals that developed ARF. These are similar findings to the temporal course seen in humans where liver injury is detected early and renal injury is often one of the final organs to fail. 21 This model had histological evidence of ARF, which has been detected in only a few rat CLP studies such as ARF, acute renal failure; 2D, two-dimensional; MW, molecular weight; pI, isoelectric point. Proteins were identified by matrix-assisted laser desorption/ionization-time-of-flight-time-of-flight. The spot numbers are as used in Figure 8 . The change is expressed as fold increase or decrease when ARF is compared to no ARF. A positive percentage indicates an increase with ARF, a negative indicates a decrease with ARF. The measured MW and measured pI were determined from the 2D gel. Also shown is the predicted MW and pI. The identifications were made by peptide mass fingerprinting and tandem mass spectrometry for most proteins and the scores are shown as a percentage.
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Huber-Lang et al. 22 and Rhodes et al. (Rhodes GJ, Sandoval RM, Molitoris BA: Intravital 2-photon visualization of alterations in the rat kidney during sepsis. J Am Soc Nephrol SA-PO704, 2004 (Abstract)) and in the mouse model developed by our lab. 6 Renal histological damage was observed at 24 h after CLP; however, injury was delayed, as no changes were detected 8 h after CLP. At 24 h, loss of the brush border, slight vacuolization and exfoliated cells were evident. Human renal histological damage after sepsisinduced ARF is poorly described, however, Sato et al. 23 found modest vacuolization and flattening of the brushborder membrane in an 'immediate (human) autopsy.' This may be similar to our rat model.
Induction of pro-and anti-inflammatory cytokines is well documented in sepsis. [24] [25] [26] We measured levels of IL-6, IL-10, and TNF-a early (8 h) and late (24 h) to establish a time course of cytokine response. Both IL-6 and IL-10 were elevated and the animals that developed ARF also showed a greater increase at each time point compared with the animals without renal injury. Demirbilek et al.
27
, showed a similar cytokine response in rats undergoing CLP surgery with an early and greater increase in IL-6 and IL-10 at 9 h compared to 18 h. Measurements of various cytokines in septic patients by numerous groups have shown correlations between levels of IL-6 with the severity of sepsis and mortality. 28 These findings are consistent with our rat model as the rats with ARF were more severely injured and had higher levels of IL-6. TNF-a was undetectable in all groups. While TNF-a has been shown to be significantly elevated in patients with sepsis, Damas et al.
29
, found that during acute episodes of septic shock, TNF-a was only elevated for a few hours and did not remain elevated. It is therefore possible that TNF-a levels were elevated in our rat model but returned to baseline by 8 h after CLP surgery.
We also measured levels of nitrite in the blood as an indicator of NO production. Blood nitrite was elevated as a result of sepsis at 8 and 24 h with a larger increase at 24 h. Animals that developed ARF also showed a greater increase in blood nitrite content at 8 h compared to the animals where ARF was absent. NO has been proposed to be involved in the pathogenesis of sepsis and multi-organ failure, although there are conflicting reports as to its role and significance. 30 In summary, our rat model has similarities with human sepsis and its heterogeneous response can be utilized to discover novel drug targets.
Biomarker and drug-target discovery using proteomics
In this paper, we used DIGE to investigate the urinary proteome. This approach allowed comparison of urine from septic rats without and with ARF. We discovered that a number of proteins had significantly different expression levels. Urinary albumin excretion was increased in rats with ARF, consistent with other studies demonstrating increased albuminuria in rodent models of sepsis-induced ARF. 31 Mammalian plasma contains SPI regulating various processes including coagulation, inflammation, and complement activation. 32 Using proteomics we found that urine from septic rats with ARF had decreased amounts of SPI. This is in keeping with the urinary levels of SPI reflecting the plasma levels. Studies by other groups have found plasma levels of SPI decreased with sepsis in rodents and humans and correlated with severity of illness. 33, 34 After administration of endotoxin, renal injury is more severe in mice lacking SPI. 35 Pro-inflammatory cytokines and chemokines are elevated in the kidneys of mice lacking SPI which suggests that SPI action may not be solely inhibition of proteases but also inhibition of cytokine and chemokine action. Treatment with exogenous SPI improves survival in rodent models. 33, 34 Using DIGE and immunoblotting we also found changes in tubular brush-border enzymes. Meprin is a brush-border enzyme which plays a role in renal ischemia-reperfusion injury. Meprin inhibition prevents hypoxic injury in vitro and ischemia-reperfusion injury in vivo. 13 Aminopeptidase is established as a marker of renal injury after exposure to nephrotoxins such as antibiotics and contrast agents. 36, 37 This protein is a brush-border enzyme and its increase in the urine following sepsis-induced ARF reflects the loss of the renal tubular brush border on histology.
However, gel-based proteomics has limitations. Within the two groups (sepsis without ARF and sepsis with ARF) there was considerable variability in the protein (mainly prostatic proteins) excreted in the urine. The artifacts from this variability were managed by pooling the samples, an approach that has been validated for microarray analysis and is especially valuable in studies when small numbers of samples are used. 38 Despite finding changes in the urinary proteome, we did not detect established ARF biomarkers such as lipocalin, 39 CYR 61, 40 and KIM-1; 41 therefore, we were unable to determine whether they changed in abundance. Such false negatives may occur with gel-based proteomics because of multiple reasons, such as difficulty in detecting low-abundance proteins or the inability to solublize membrane proteins. Even high-abundance, soluble proteins may not be amenable to identification by mass spectrometry because of technical limitations. Our data are by no means exhaustive, considering the small sample size and pooling. However, larger sample sizes and/or not pooling would likely yield minimal numbers of proteins changed by ARF, in addition to some false positives. Instead, approaches that are more likely to complement DIGE and result in greater coverage of the proteome might be needed, such as separation by liquid chromatography prior to identification by mass spectrometry or protein antibody arrays. 42 Also advances in mass spectrometry will increase the identification rate of interesting proteins. Despite these limitations we identified meprin-1-alpha as a potential biomarker for sepsisinduced ARF. The urinary concentration of this protein decreased with renal injury and meprin may be useful in a multivariant combination with another biomarker. If one urinary protein biomarker increases (e.g., KIM-1 or lipocalin) and meprin decreases with ARF then the ratio may improve the ability to detect subtle renal injury.
Another objective of investigating the urinary proteome was to discover novel drug targets for treatment of sepsisinduced ARF. We used actinonin to inhibit brush-border enzymes (especially meprin-1-alpha) as other groups have demonstrated that this drug reduced renal injury in the ischemia-reperfusion model of ARF. 13 While the heterogeneity of our rat model is a strength for investigating pathophysiology it is a weakness for testing therapeutics. Therefore, we changed species and used our mouse model which develops a more homogeneous amount of ARF in response to CLP. Actinonin reduced renal injury in this mouse model. Therefore, by using a heterogeneous animal model and employing proteomics we succeeded in our objective of identifying a novel drug target.
In summary, we describe a new rat model of sepsisinduced ARF. This model has marked heterogeneity in response. While this makes the model less suitable for testing therapeutics it allows comparison of 'responders' to 'nonresponders' with potential for pathophysiological insights. By using proteomics our study was able to detect changes in the excretion of abundant urinary proteins which correlated with the presence of sepsis-induced ARF. This led to our finding that inhibition of brush-border enzymes with actinonin prevented sepsis-induced ARF.
MATERIALS AND METHODS Animals
Experiments were performed in aged (4-7 months), male SpragueDawley rats weighing 450-550 g, purchased from Charles River Laboratories Inc. (Wilmington, MA, USA). Free access to water and food was allowed and animals were placed on a low potassium diet after surgery (casein 180 g, cornstarch 200 g, sucrose 500 g, CaHPO 4 10 g, MgSO 4 . 7H 2 O 6 g, NaCl 8.8 g, Na 2 HPO 4 6.8 g, KCl 3.5 g, vitamin mix (ICN Biomedicals Inc., Costa Mesa, CA, USA) 10 g, corn oil 35 ml, peanut oil 35 ml, water 50 ml). All animals were treated in accordance with the National Institutes of Health (NIH) guidelines for use and care of research animals.
CLP sepsis-induced ARF -Group 1 Rats were anesthetized with 1.5% isoflurane. The abdomen was shaved, cleaned with betadine solution, and a 3 cm incision was made. The cecum was removed and ligated 0.75 cm from the cecal tip with a 5-0 silk suture, punctured, and the cecal contents of the ligated section was emptied into the peritoneal cavity. A second section was ligated 1.5 cm proximal to the first ligature. The cecum was punctured three times with an 18-gauge needle and gently squeezed to ensure patency of puncture sites. The abdominal contents were returned and the abdomen was closed in two layers with 4-0 nylon sutures. Immediately after surgery, 24 ml/kg of pre-warmed normal saline was given intraperitoneally. Animals were housed at 291C for 24 h after surgery. Animals were treated with 2/3 normal saline (40 ml/kg) and broad-spectrum antibiotics (imipenem and cilastatin; 14 mg/kg) by subcutaneous injection at 6 and 18 h after surgery. Buprenorphine was given as an analgesic at 0, 6, and 18 h (0.1 mg/kg, subcutaneously). Blood was collected at 8 h for blood chemistry, nitrite, and cytokine measurements. Animals were killed at 24 h after surgery (Figure 1 ). At killing, blood was drawn, and the kidneys and liver were harvested for histology (Group 1, n ¼ 63).
To validate rat urinary proteins as potential drug targets a mouse CLP model was used.
6 C57BL/6 mice (11 months old ) were anesthetized using isoflurane inhalation. After laparotomy, a 5-0 silk ligature was placed 1 cm from the cecal tip. The cecum was punctured twice with a 21-gauge needle and gently squeezed to express a 1 mm column of fecal material. The abdominal incision was closed in two layers with 6-0 nylon sutures. After surgery, 1 ml of pre-warmed normal saline was given intraperitoneally. All animals received a broad-spectrum antibiotic (imipenem/cilastatin; 14 mg/kg subcutaneously) at 6 h, and 1.5 ml of 3/4 normal saline was administered at 6 and 18 h after surgery by subcutaneous injection. There was an increase in body weight of 771% at 24 h, (n ¼ 36). Buprenorphine was given as an analgesic at 0, 6, and 18 h (0.1 mg/ kg, subcutaneously). Mice received either actinonin (400 mg intraperitoneally at 0 and 6 h post-CLP) or normal saline vehicle. At the time of killing, blood was collected by cardiac puncture for measurement of serum creatinine by high-performance liquid chromatography.
Blood chemistries and serum cytokine measurements Serum creatinine was measured by picric acid-based colorimetric autoanalyzer (Astra 8 autoanalyzer; Beckman Instruments, Fullerton, CA, USA) and by high-performance liquid chromatography method as previously described. 43 Chemistry measurements of serum blood urea nitrogen, alkaline phosphatase, alanine transaminase, aspartate transaminase, amylase, creatine kinase, lactase dehydrogenase, albumin, total protein, and uric acid were measured using an autoanalyzer (Hitachi 917, Boehringer Mannheim, Indianapolis, IN, USA). Serum levels of rat IL-6, IL-10, and TNF-a were assayed by enzyme-linked immunosorbent assay (Quantikine, R&D Systems Inc., Minneapolis, MN, USA).
Nitrite measurements NO is difficult to measure because of its short half-life in the blood and tissues. 44 Nitrite is proposed to be a major vascular storage pool of NO, so we measured nitrite in the blood as a surrogate of NO. 45 To avoid nitrite oxidation by oxyhemoglobin and reduction by deoxyhemoglobin that occurs ex vivo after blood collection, whole blood nitrite concentration was measured by the method of Dejam et al. 46 Briefly, whole blood was drawn and immediately added to a nitrite preservation solution (1.32 g K 3 Fe(CN)6, 4.5 ml H 2 O, 0.0625 g N-ethylmaleimide, 500 ml Nonidet P40) in a ratio of 5:1. The samples were stored at À801C until measured. Samples were deproteinated with the addition of methanol (1:1) and centrifuged for 2 min. Each sample (20-200 ml) was injected into a gas-phase chemiluminescence NO analyzer (Sievers, Boulder, CO, USA) and a peak corresponding to the nitrite concentration was measured.
Histology
Kidney and liver were fixed in 10% formalin, paraffin-embedded, sectioned, (4 m), and stained with periodic acid-Schiff reagent. Sections were examined under Â 400 magnification for renal and hepatic damage. Our histological criteria for renal damage were vacuolization of proximal tubule cells, loss of the brush border and exfoliation of cells into the tubular lumen. Hepatic sections were examined for decreased staining, vesicular nuclei and opening of the sinusoids.
Urine collection and urinary creatinine measurementsGroup 2 A second group of animals were housed in a metabolic cage for collection of urine before and after surgery. Urine was collected before surgery (À22 to À16 h) and 2-8 h after CLP surgery. Both collections were at the same time of day to prevent changes caused by circadian rhythms (Figure 1 ). To avoid urine changes caused by giving 6-h fluids in the middle of urine collection, animals in the metabolic cages were instead given fluids at 8 and 18 h. There was an increase in body weight of 771% at 24 h (n ¼ 6), which was not significantly different between Groups 1 and 2 (P40.05). Urine was collected on ice with protease inhibitors (0.1 mg/ml leupeptin, 0.1 mg/ml PMSF, 1mM sodium azide, in 1 M Tris pH 6.8) in a 1:10 ratio of buffer to urine. The urine was centrifuged at 100 g for 5 min, the supernatant filtered (0.22 mm Millex-GS, Millipore, Billerica, MA, USA), and stored at À801C. Urinary creatinine was measured by an i-STAT portable clinical analyzer (Abbott Laboratories Inc., Abbott Park, IL, USA).
2D DIGE
We investigated changes in the urinary proteome that could represent potential biomarkers and drug targets for ARF by comparing urine from septic rats with normal renal function (non-responders) to the urine from septic rats with ARF (responders). Urinary protein was precipitated by addition of 50% ice-cold acetone followed by centrifugation at 95 g for 5 min. The protein pellet was solubilized in lysis buffer containing 30 mM Tris, pH 8.8, 7 M urea, 2 M thiourea, 4% 3-[3-cholamidopropyl-1]dimethylammonio)-1-propanesulfonate and the protein concentration was determined using the 2D Quant kit (Amersham, Piscataway, NJ, USA). The amount of protein labeled from each rat corresponded to the same duration of urine collection (see Results). The samples were then minimally labeled with Cy3 and Cy5 dyes as per manufacturer's instructions (200 pmol per sample). Cy3-and Cy5-labeled samples were mixed together and rehydration buffer was added (7 M urea, 2 M thiourea, 4% 3-[3-cholamidopropyl-1]dimethylammonio)-1-propanesulfonate, 0.5% pharmalytes (Amersham), 40 mM dithiothreitol, and 0.002% bromophenol blue). Experiments were run in triplicate; one of the triplicate experiments had unlabeled urinary protein added to a final protein content of 500 mg. The mixed samples were then loaded on an immobilized pH gradient strip (24 cm; pH 3-10 NL) for isoelectric focusing according to the following protocol: 30 V for 14 h (active rehydration), 500 V for 500 Vh, 1000 V for 1000 Vh, and 8000 V for 66,667 Vh. Strips were equilibrated for 15 min in a solution containing 50 mM Tris Á HCl, pH 8.8, 6 M urea, 30% glycerol, 2% sodium dodecyl sulfate, 0.002% bromophenol blue, and 65 mM dithiothreitol followed by a second 15-min equilibration with iodoacetamide (25 mg/ml) instead of dithiothreitol. Strips were briefly rinsed in 1 Â sodium dodecyl sulphate-polyacrylamide gel electrophoresis buffer and applied to a 12.5% polyacrylamide gel for electrophoresis at 5 W/gel for 30 min followed by 17 W/gel for 4 h.
Image acquisition and analysis
Images were scanned on a Typhoon 9400 variable mode imager (Amersham Biosciences) at an excitation wavelength of 670/30 (maxima/bandwidth) for Cy5 (laser 633 -red) or 580/30 for Cy3-(laser 532 -green) labeled samples. The laser power was adjusted to avoid signal saturation. The resolution was 100 mm. Images were then processed with DeCyder Differential In Gel AnalysisV4.0 software (Amersham Biosciences) to identify changes in spot fluorescence intensities.
After protein spots were designated to be picked, the gel with 500 mg protein was fixed in 10% methanol and 7% acetic acid for 1 h and incubated in SYPRO Ruby protein gel stain (Bio-Rad) for at least 2 h. Then it was washed in 10% methanol and 7% acetic acid for 1 h. Next, the gel was scanned at an excitation wavelength of 610/ 30 (laser 532) to visualize all proteins present in the gel. CyDye-and SYPRO-derived images were matched using DeCyder Biological Variation Analysis V4.00.07 software (Amersham Biosciences), from which a pick list was generated.
Spot picking and protein processing
The Ettan Spot Handling Workstation was used to cut out the selected protein spots from the 500 mg protein gel, perform an in-gel tryptic digestion, extract the peptides from the gel, and transfer the digested proteins on to a matrix-assisted laser desorption/ionization-time-of-flight/Pro (Amersham Biosciences) sample slide. Peptides were analyzed using a 4700 Proteomics Analyzer (Applied Biosystems) tandem mass spectrometer.
Western blotting
Urinary protein was precipitated by addition of 50% ice-cold acetone followed by centrifugation at 95 g for 5 min. The proteins were resuspended in Laemmli sample buffer then fractionated on a 7.5% polyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was blocked in 5% rabbit serum in Tris-buffered saline containing 0.1% Tween 20. The membrane was incubated with 1:500 meprin 1a primary antibody (Santa Cruz Biotech, CA, USA) overnight then incubated with horseradish peroxidase-conjugated donkey anti-goat immunoglobulin. The reaction products were visualized by chemiluminescence (ECL-plus; Amersham) using BioMax MR film (Eastman Kodak, Rochester, NY, USA).
Statistical analysis
All data are expressed as mean7s.e. Differences between groups were analyzed for statistical significance by analysis of variance or t-test. Different outcomes in renal function 24 h after CLP surgery were evaluated by a w 2 test. A P-value o0.05 was accepted as statistically significant.
